Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein
暂无分享,去创建一个
Tetsuya Ikemoto | Hiroki Mori | Tohru Utsunomiya | Satoru Imura | Mitsuo Shimada | Yu Saito | T. Utsunomiya | Y. Morine | M. Shimada | S. Imura | T. Ikemoto | H. Mori | J. Hanaoka | Yu Saito | S. Yamada | Yuji Morine | Jun Hanaoka | Shinichiro Yamada | Michihito Asanoma | M. Asanoma
[1] H. Yoshida,et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers , 2006, Hepatology.
[2] H. Miyake,et al. Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion. , 2008, Hepato-gastroenterology.
[3] W. Lau,et al. Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection , 2011, Annals of Surgical Oncology.
[4] Y. Maehara,et al. LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: A SPECIAL REFERENCE TO A PREOPERATIVE DES-GAMMA-CARBOXY PROTHROMBIN VALUE. , 2004, Transplantation proceedings.
[5] T. Ono,et al. Fucosylation of serum α-fetoprotein in patients with primary hepatocellular carcinoma , 1985 .
[6] J. Bręborowicz,et al. Microheterogeneity of Alpha‐fetoprotein in Patient Serum as Demonstrated by Lectin Affino‐electrophoresis , 1981, Scandinavian journal of immunology.
[7] M. Makuuchi,et al. Accurate preoperative evaluation of liver mass lesions without fine‐needle biopsy , 1999, Hepatology.
[8] K. Taketa. Alpha-fetoprotein: reevaluation in hepatology. , 1990, Hepatology.
[9] H. Imamura,et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC , 2010, Journal of Gastroenterology.
[10] Shou-Dong Lee,et al. Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma , 1984 .
[11] S. Strasberg,et al. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. , 2005, Journal of hepato-biliary-pancreatic surgery.
[12] T. Ishiko,et al. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma , 2010, Journal of surgical oncology.
[13] K. Sung,et al. Lens culinaris Agglutinin-Reactive Alpha-Fetoprotein as a Prognostic Marker in Patients With Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization , 2002, Journal of clinical gastroenterology.
[14] S. Satomura,et al. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. , 1999, Journal of hepatology.
[15] T. Kuzuya,et al. Relationship between Lens culinaris agglutinin‐reactive α‐fetoprotein and pathologic features of hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[16] Hideyuki Shimizu,et al. Usefulness of measurement of lens culinaris agglutinin-reactive fraction of α-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma , 1999, American Journal of Gastroenterology.
[17] B. Furie,et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. , 1984, The New England journal of medicine.
[18] T. Ono,et al. Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma. , 1985, Biochimica et biophysica acta.
[19] H. Asakura,et al. The fucosylation index of α‐fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma , 1998 .
[20] K. Taketa. α‐fetoprotein: Reevaluation in hepatology , 1990 .
[21] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[22] Y. Hiasa,et al. Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment , 2010, Digestive Diseases and Sciences.